“…In recent years, with the advancement of targeted therapy, more and more clinical treatments for malignant tumors have gradually adopted targeted therapy. Therefore, in-depth research on the pathogenesis and causes of CC and the search for new therapeutic targets is of great clinical significance in improving patients' clinical symptoms, slowing down the progression of cancer and improving their quality of life (3). Dual specificity phosphatase 1 (DUSP1) belongs to the protein complex phosphatase gene superfamily that is a regulator of tumor suppressors and cancer-related inflammation (4).…”